| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.00044 | 1 |